ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab ...
Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by firm, itchy, and often painful bumps (nodules) on the skin. It typically begins with intense itchiness, which can be ...
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.Printer-Friendly Email This Download This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback